4//SEC Filing
MARDUEL ALIX 4
Accession 0001209191-08-020306
CIK 0001088856other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 6:02 PM ET
Size
12.2 KB
Accession
0001209191-08-020306
Insider Transaction Report
Form 4
MARDUEL ALIX
Director
Transactions
- Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund) - Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying) - Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying) - Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)
Footnotes (3)
- [F1]These securities are held by Alta BioPharma Partners II, L.P. ("ABPII").
- [F2]The Reporting Person is a managing director of Alta BioPharma Management II, LLC ("ABMII"), which is the general partner of ABPII , and a manager of Alta Embarcadero Partners II, LLC ("AEBPII" and, along with ABPII, the "Funds"). The Reporting Person may be deemed to share voting and investment power over the shares held by the Funds. The Reporting Person disclaims beneficial ownership of all such shares held by the Funds, except to the extent of her pecuniary interests therein.
- [F3]These securities are held by AEBPII.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001198328
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 6:02 PM ET
- Size
- 12.2 KB